Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in ARGX — Argenx SE

CIK 1452765 NEW YORK, NY

Position in ARGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,079,924
+$809,827 QoQ
Shares Held
1,164
+137.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#238
of 496 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Derivatives in ARGX

reported options exposure · as of Dec 31, 2023
CallValue
$418,473
CallShares
1,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names. ARGX ranks #1 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
This page
1,164 $1,079,924

All Filings in ARGX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,079,924 1,164
2025-06-30 $270,097 490
2025-03-31 $372,283 629
2024-12-31 $308,115 501
2024-09-30 $1,101,506 2,032
2023-12-31 $418,473 1,100
2023-09-30 $847,078 1,723
2023-09-30 $786,608 1,600
2023-09-30 $2,408,987 4,900